![]() |
市场调查报告书
商品编码
1802010
全球药用明胶市场规模、份额及成长分析(按产品类型、应用、来源、最终用户和地区)- 产业预测(2025-2032)Pharmaceutical Gelatin Market Size, Share, and Growth Analysis, By Product Type (Type A, Type B), By Application (Capsules, Tablets), By Source, By End-User, By Region - Industry Forecast 2025-2032 |
预计 2023 年全球药用明胶市场价值将达到 11 亿美元,到 2032 年将从 2024 年的 11.6 亿美元增长到 17.5 亿美元,预测期内(2025-2032 年)的复合年增长率为 5.3%。
由于老年人口成长和慢性病盛行率上升,对胶囊和明胶类药物的需求不断增长,全球药用明胶市场预计将持续成长。生物製药和疫苗研发的蓬勃发展进一步提升了市场潜力。软胶囊和硬胶囊製剂的流行证实了明胶在消费者寻求易于服用的药物选择方面所发挥的重要作用。此外,不断扩张的营养保健品产业,尤其是在註重健康的市场,也对这一趋势做出了积极的贡献。然而,市场也面临许多挑战,例如对动物源性明胶的担忧,以及饮食和宗教限制,促使人们转向植物来源品。虽然这些因素可能会阻碍某些地区更广泛的策略实施,但它们也为产业创新带来了机会。
Global Pharmaceutical Gelatin Market size was valued at USD 1.1 billion in 2023 and is poised to grow from USD 1.16 billion in 2024 to USD 1.75 billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032).
The global pharmaceutical gelatin market is poised for growth driven by an increasing demand for capsule and gelatin-based medications, fueled by a growing geriatric population and the rising prevalence of chronic diseases. The surge in biopharmaceuticals and vaccine development further enhances market potential. The popularity of soft gel and hard capsule formulations underscores the integral role of gelatin, as consumers seek easy-to-consume options for medication. Additionally, the expanding nutraceutical sector, particularly in health-conscious markets, contributes positively to this trend. However, the market faces challenges from concerns regarding animal-derived gelatin, along with dietary and religious restrictions, prompting a shift toward plant-based alternatives. Although these factors may hinder broader strategies in certain regions, they provide opportunities for innovation within the industry.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Gelatin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Gelatin Market Segments Analysis
Global Pharmaceutical Gelatin Market is segmented by Product Type, Application, Source, End-User and region. Based on Product Type, the market is segmented into Type A and Type B. Based on Application, the market is segmented into Capsules, Tablets, Suppositories and Vaccines. Based on Source, the market is segmented into Porcine, Bovine and Fish. Based on End-User, the market is segmented into Pharmaceuticals, Nutraceuticals and Cosmetics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Gelatin Market
The increasing demand for pharmaceutical products in capsule form is significantly fueling the Global Pharmaceutical Gelatin market. Gelatin capsules offer advantages such as ease of swallowing and enhanced bioavailability, making them a vital component in both prescription and over-the-counter medications. This growing interest among consumers and healthcare providers underscores the importance of gelatin in the pharmaceutical industry, leading to consistent and robust market growth. The versatility and functional benefits of gelatin capsules continue to contribute to their popularity, further solidifying their role in the development of innovative drug delivery systems across various therapeutic areas.
Restraints in the Global Pharmaceutical Gelatin Market
The rising inclination towards vegan, vegetarian, and plant-based lifestyles has significantly shifted consumer preferences towards non-animal gelatin alternatives. This trend is particularly evident in the nutraceutical and dietary supplement sectors, where the demand for plant-based capsules is gaining traction. Consequently, traditional gelatin products face growing competition, especially in markets where health-consciousness and vegan considerations are paramount. This shift poses a challenge for manufacturers of animal-derived gelatin, as they must adapt to the changing landscape and address the needs of consumers who prioritize ethical and health-related factors in their purchasing decisions.
Market Trends of the Global Pharmaceutical Gelatin Market
The global pharmaceutical gelatin market is witnessing significant growth driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular issues, and arthritis, which necessitate consistent medication solutions. The demand for patient-friendly drug delivery formats, particularly gelatin capsules and soft gel capsules, is rising due to their ease of administration and precise dosing. This preference for convenient and effective medication delivery is propelling the expansion of the pharmaceutical gelatin market across various therapeutic segments. As healthcare providers seek innovative ways to enhance patient compliance and treatment outcomes, the versatility and functionality of gelatin in pharmaceuticals continue to bolster market potential.